Forty years of combinatorial technology.

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Drug Discovery

Background:

• Combinatorial technology has enabled the synthesis and screening of large molecular libraries for 40 years.
• It shifted pharmaceutical research from single compounds to vast collections.
• This technology inspired new approaches like dynamic combinatorial libraries and fragment-based drug discovery.

Purpose of the Study:

• To highlight the evolution and impact of combinatorial technology in drug discovery.
• To emphasize the transformative role of DNA encoding in revitalizing combinatorial screening.
• To showcase the potential of DNA-encoded libraries for screening billions of compounds.

Main Methods:

• Utilizing DNA encoding for molecular library synthesis and tagging.
• Employing amplification of DNA oligomers for signal enhancement.
• Leveraging next-generation sequencing for high-throughput screening of compound libraries.

Main Results:

• Demonstrated the successful screening of billions of compounds in a single process.
• Showcased the revitalization of combinatorial technology through DNA encoding.
• Enabled a paradigm shift towards screening immense molecular collections in pharmaceutical research.

Conclusions:

• DNA-encoded technology has significantly advanced combinatorial screening capabilities.
• This approach allows for unprecedented scale in identifying potential drug candidates.
• Combinatorial technology, especially with DNA encoding, remains a cornerstone of modern drug discovery.